swish30

** ONCS dip buy for potential running upside on clinical data

做多
NASDAQ:ONCS   None
Usually clinical data isn't super positive on day 2 but these guys recently raised money, Point72 bought into the company. Almost no shares to short out there.

Today I expect this to trade around 2.15 in decent size. Looking to buy on dips for instant profit and potentially hold some for a run up to $3

免责声明

这些信息和出版物并不意味着也不构成TradingView提供或认可的金融、投资、交易或其它类型的建议或背书。请在使用条款阅读更多信息。